Business Wire

Seda Packaging Group: Revolutionary New Paper Lid Delivers Integrated Sustainable Drinking Solutions

23.1.2025 06:00:00 CET | Business Wire | Press release

Share

Seda International Packaging Group’s versatile new EcoFit Lids offer complete plastic reduction and the lowest energy and water consumption manufacturing process

In a radical development significantly advancing sustainability, Seda International has proudly introduced its innovative EcoFit Lid on the market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122180654/en/

null

The compostable Double Wall cold cups with EcoFit lids for a superior beverage experience (Photo: Luciano Romano)

The EcoFit Lid has been thoughtfully designed to completely replace traditional plastic lids with a leak- and spill-resistant solution that delivers a superior drinking experience for hot and cold beverages alike. Enhancing safety, an audible snap confirms it has engaged fully with the cup rim for a secure, tight fit that’s better both in-store and during delivery.

Conceived following Seda’s rigorous ecodesign principles, the EcoFit Lid is also an exceptionally flexible and versatile solution. Available in Flat & Domed options, each offers a choice of triangular or oval sip hole with either a C-cut, cross-cut or Push & Lift action to provide a fully-tailored consumer experience and brand personality.

Crafted from 100% certified renewable fibres, the EcoFit lid can be combined with Seda’s cutting-edge printing technology to offer exceptional branding opportunities. It has the lowest environmental impact of any fibre lid in terms of CO₂ Emissions and Water Consumption for the entire supply chain, from cradle to grave.

A Life Cycle Assessment (LCA) conducted using EU data has conclusively demonstrated the EcoFit lid's superiority over other lid options, including moulded fibre and plastic PS and PP lids. This was confirmed by a recent Seda gate-to-gate screening showing EcoFit’s substantial environmental benefits, including significantly lower production cycle water and energy consumption as well as carbon emissions than even moulded fibre lids.

Fully recyclable in the paper stream and also available in a compostable version to meet all needs and usage scenarios, the EcoFit Lidis set to massively reduce the depletion of fossil resources caused by current plastic lids, saving 400 tons of plastic for every 100 million lids.

Brands can consequently make measurable progress towards reducing their environmental impact by choosing EcoFit Lids to support their sustainability goals and contribute to a lower carbon footprint in the packaging supply chain.

Equally important, the EcoFit Lid is not an isolated solution but has been expressly designed to form an integrated, fully sustainable package with Seda’s Double Wall cups. An original Seda innovation developed for hot beverages and patented in the early 2000s, the Double Wall Cup has set the industry standard ever since.

Seda’s more recently introduced Double Wall Cold Cups are made from the same sustainable, printable paperboard and have likewise been conceived to deliver a superior drinking experience. Their unique, patented air gap design ensures beverages stay cold for longer, while greatly reducing condensation and sweating to provide a much more enjoyable tactile sensation compared with single wall cold cups made of paper or plastic. Consumers appreciate how their drinks remain cool and satisfying without worrying about condensation or slippery cups, making each sip as refreshing as the first.

These cups and lids have been specifically designed to meet the growing demands of evolving legislation across Europe that increasingly favours sustainable packaging solutions. Seda’s new offering thus provides a transformative solution for businesses that need to rapidly adapt to new environmental regulations.

“Our new EcoFit Lids and compostable Double Wall cold cups underscore Seda Group’s dedication to continuous innovation and sustainability,” said Armando Mariano, Director of Innovation, R&D, Materials, and Sustainability at Seda Group. “These products were designed with the future in mind, addressing environmental concerns and evolving consumer demands. By significantly reducing water consumption and CO2 emissions, our EcoFit Lid sets a new benchmark in sustainable beverage packaging. We are proud to offer solutions that not only comply with stringent regulations but also enhance the consumer experience while helping brands make meaningful progress towards their sustainability goals.

As European consumers increasingly demand more sustainable products, Seda continues to lead the market with the most innovative and sustainable packaging solutions, consistently delivering top-quality products that meet customer expectations with outstanding service.

Leading coffee, restaurant, and convenience store brands worldwide are already adopting these innovations to meet their sustainability objectives.

Seda International Packaging Group is a leading provider of sustainable food and food service packaging solutions. Headquartered in Naples, Italy, Seda operates manufacturing platforms across Italy, Germany, Portugal, the UK and North America.

Discover more about Seda at www.sedagroup.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250122180654/en/

null
null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye